📰 Highlights Operational News

Highlights Operational News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Highlights Operational. Real-time updates on events, politics, business and more.

Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress

May 16, 2023

Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress Halle (Saale) / Munich, Germany, May 16, 2023 - Vivoryon Therapeutics N.V. (Euronext

Noord Holland Kugan Sathiyanandarajah Valeria Fisher Dinnies Johannes Julie Seidel Ulrich Dauer

Source: finanznachrichten.de

Vivoryon Therapeutics N.V. Reports Full Year 2022 Financial

April 19, 2023

Vivoryon Therapeutics N.V. Reports Full Year 2022 Financial Results and Highlights Operational Progress Significantly advanced varoglutamstat EU and...

Macau General Vastra Gotalands Lan South Australia Hong Kong Claus Christiansen Ulrich Dauer

Source: globenewswire.com

Vivoryon Therapeutics N.V. Reports Full Year 2022 Financial Results and Highlights Operational Progress

April 19, 2023

Vivoryon Therapeutics N.V. Reports Full Year 2022 Financial Results and Highlights Operational Progress Significantly advanced varoglutamstat EU and U.S. clinical studies, VIVIAD and VIVA-MIND

Macau General Hong Kong Vastra Gotalands Lan South Australia Claudia Riedl Valeria Fisher

Source: finanznachrichten.de

EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Third Quarter 2022 Financial Results and Highlights Operational Progress

November 22, 2022

EQS-News: Vivoryon Therapeutics N.V. / Key word(s): 9 Month figures Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Third Quarter 2022 Financial Results and Highlights Operational Progress (news with additional features) 22.11.2022 / 07:20 CET/CEST The issuer is solely responsible...

South Australia United States United Kingdom Noord Holland Julie Seidel Valeria Fisher

Source: boersennews.de

EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2022 Financial Results and Highlights Operational Progress

September 30, 2022

EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Half Year Results Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2022 Financial Results and Highlights Operational Progress

United States United Kingdom San Diego Mecklenburg Vorpommern Noord Holland Claudia Riedl

Source: finanznachrichten.de

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highlights Operational Progress

June 15, 2022

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Interim Report Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1...

Valeria Fisher Ulrich Dauer Manuela Bader National Medical Products Administration Trophic Communications China Center

Source: businessinsider.com

DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highlights Operational Progress

June 15, 2022

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Interim Report Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highlights Operational Progress

Noord Holland Valeria Fisher Ulrich Dauer Halle Saale Manuela Bader Company Annual

Source: finanznachrichten.de

DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highlights Operational Progress Seite 1

June 15, 2022

15.06.2022 - DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Interim Report Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highlights Operational Progress (news with additional features) 15.06.2022 / 07:00 ... Seite 1

Ulrich Dauer National Medical Products Administration China Center Highlights Operational Euronext Amsterdam European Phase

Source: wallstreet-online.de

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highli

June 15, 2022

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Interim ReportVivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highlights Operational Progress (news with additional features)15.06.2022 / 07:00 The issuer is solely responsible for the content of this announcement.&nbs...

Valeria Fisher Ulrich Dauer Manuela Bader Company Annual National Medical Products Administration Trophic Communications

Source: pharmiweb.com